Page last updated: 2024-10-29

ifosfamide and Carcinoma, Lewis Lung

ifosfamide has been researched along with Carcinoma, Lewis Lung in 1 studies

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misiura, K1
Kinas, RW1
Kuśnierczyk, H1
Radzikowski, C1
Stec, WJ1

Other Studies

1 other study available for ifosfamide and Carcinoma, Lewis Lung

ArticleYear
(S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
    Anti-cancer drugs, 2001, Volume: 12, Issue:5

    Topics: Animals; Antineoplastic Agents, Alkylating; Biological Availability; Carcinoma, Lewis Lung; Chromato

2001